MedTrace Logo

On-site Supportive Communication Training in Doctor-patient Communication

NCT05842083 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 89

Last updated 2024-06-26

No results posted yet for this study

Summary

The goal of this randomized, controlled clinical trial is to test a new concept for communication skills training (on-site supportive communication training (on-site SCT) in cancer care. The study aims to determine the impact of on-site SCT on patients' rating of oncologists' communication abilities.

Oncologists participating in the study will be randomly allocated to the intervention or control group. In the intervention group each doctor will have a total of three intervention days at intervals of 3-4 weeks. On an intervention day, a psychologist will sit in and observe doctor-patient consultations. After the first consultations, 30 minutes are allocated for feedback to the doctor by the psychologist. After the last consultation of the day, 60 minutes are allocated for thorough feedback and establishment of learning goals to focus on until the next intervention day. Doctor's in the control group will conduct communication as usual.

Researchers will compare the control and intervention groups to see if patients' rating of doctors' interpersonal and communication skills increase when the doctors have participated in on-site SCT. The 15-item Communication Assessment Tool (CAT) will be used.

It will also be investigated whether on-site SCT increases the doctors' rating of themselves in relation to communication efficacy and job satisfaction and decrease their experience of burnout.

Conditions

  • Communication Programs
  • Communication, Manual
  • Communication Research
  • Oncology
  • Doctor Patient Relation
  • Job Stress
  • Burnout
  • Satisfaction, Patient
  • Efficacy, Self

Interventions

BEHAVIORAL

On-site supportive communication training

On-site supportive communication training

Sponsors & Collaborators

  • Zealand University Hospital

    collaborator OTHER

  • Aalborg University Hospital

    collaborator OTHER

  • Vejle Hospital

    lead OTHER

Principal Investigators

  • Kerstin Kiis Antonsen, MD · University Hospital of Southern Denmark - Vejle Hospital

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-05-01
Primary Completion
2024-06-25
Completion
2024-06-25

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05842083 on ClinicalTrials.gov